Literature DB >> 31304001

A MedChem toolbox for cereblon-directed PROTACs.

Christian Steinebach1, Izidor Sosič2, Stefanie Lindner3, Aleša Bricelj2, Franziska Kohl1, Yuen Lam Dora Ng3, Marius Monschke4, Karl G Wagner4, Jan Krönke3, Michael Gütschow1.   

Abstract

A modular chemistry toolbox was developed for cereblon-directed PROTACs. A variety of linkers was attached to a CRBN ligand via the 4-amino position of pomalidomide. We used linkers of different constitution to modulate physicochemical properties. We equipped one terminus of the linker with a set of functional groups, e.g. protected amines, protected carboxylic acids, alkynes, chloroalkanes, and protected alcohols, all of which are considered to be attractive for PROTAC design. We also highlight different opportunities for the expansion of the medicinal chemists' PROTAC toolbox towards heterobifunctional molecules, e.g. with biotin, fluorescent, hydrophobic and peptide tags.

Entities:  

Year:  2019        PMID: 31304001      PMCID: PMC6596386          DOI: 10.1039/c9md00185a

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  46 in total

1.  Metal-free triazole formation as a tool for bioconjugation.

Authors:  Sander S van Berkel; A Ton J Dirks; Marjoke F Debets; Floris L van Delft; Jeroen J L M Cornelissen; Roeland J M Nolte; Floris P J T Rutjes
Journal:  Chembiochem       Date:  2007-09-03       Impact factor: 3.164

Review 2.  Cu-catalyzed azide-alkyne cycloaddition.

Authors:  Morten Meldal; Christian Wenzel Tornøe
Journal:  Chem Rev       Date:  2008-08       Impact factor: 60.622

3.  Functional virus-based polymer-protein nanoparticles by atom transfer radical polymerization.

Authors:  Jonathan K Pokorski; Kurt Breitenkamp; Lars O Liepold; Shefah Qazi; M G Finn
Journal:  J Am Chem Soc       Date:  2011-05-31       Impact factor: 15.419

4.  Efforts toward elucidating Thalidomide's molecular target: an expedient synthesis of the first Thalidomide biotin analogue.

Authors:  Scott G Stewart; Carlos J Braun; Marta E Polomska; Mahdad Karimi; Lawrence J Abraham; Keith A Stubbs
Journal:  Org Biomol Chem       Date:  2010-07-13       Impact factor: 3.876

5.  Cell-penetrating penta-peptides and Bax-inhibiting peptides: protocol for their application.

Authors:  Jose Gomez; Shigemi Matsuyama
Journal:  Methods Mol Biol       Date:  2011

6.  Suborganelle sensing of mitochondrial cAMP-dependent protein kinase activity.

Authors:  Richard S Agnes; Finith Jernigan; Jennifer R Shell; Vyas Sharma; David S Lawrence
Journal:  J Am Chem Soc       Date:  2010-05-05       Impact factor: 15.419

7.  Identification of a primary target of thalidomide teratogenicity.

Authors:  Takumi Ito; Hideki Ando; Takayuki Suzuki; Toshihiko Ogura; Kentaro Hotta; Yoshimasa Imamura; Yuki Yamaguchi; Hiroshi Handa
Journal:  Science       Date:  2010-03-12       Impact factor: 47.728

8.  Bax-inhibiting peptide derived from mouse and rat Ku70.

Authors:  Tomoyuki Yoshida; Ikuo Tomioka; Takako Nagahara; Trudy Holyst; Motoshi Sawada; Paulette Hayes; Vivian Gama; Misako Okuno; Yuhong Chen; Yasuyuki Abe; Tadashi Kanouchi; Hiroshi Sasada; Demin Wang; Takanori Yokota; Eimei Sato; Shigemi Matsuyama
Journal:  Biochem Biophys Res Commun       Date:  2004-09-03       Impact factor: 3.575

Review 9.  Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides.

Authors:  J A Gomez; V Gama; T Yoshida; W Sun; P Hayes; K Leskov; D Boothman; S Matsuyama
Journal:  Biochem Soc Trans       Date:  2007-08       Impact factor: 5.407

10.  Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins.

Authors:  Taavi K Neklesa; Hyun Seop Tae; Ashley R Schneekloth; Michael J Stulberg; Timothy W Corson; Thomas B Sundberg; Kanak Raina; Scott A Holley; Craig M Crews
Journal:  Nat Chem Biol       Date:  2011-07-03       Impact factor: 15.040

View more
  11 in total

1.  Encoding BRAF inhibitor functions in protein degraders.

Authors:  Daniel S J Miller; Sabine A Voell; Izidor Sosič; Matic Proj; Olivia W Rossanese; Gregor Schnakenburg; Michael Gütschow; Ian Collins; Christian Steinebach
Journal:  RSC Med Chem       Date:  2022-05-05

2.  Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta.

Authors:  Nan Bai; Sven A Miller; Grigorii V Andrianov; Max Yates; Palani Kirubakaran; John Karanicolas
Journal:  J Chem Inf Model       Date:  2021-02-24       Impact factor: 4.956

3.  PROTACs and Building Blocks: The 2D Chemical Space in Very Early Drug Discovery.

Authors:  Giuseppe Ermondi; Diego Garcia-Jimenez; Giulia Caron
Journal:  Molecules       Date:  2021-01-28       Impact factor: 4.411

4.  Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay.

Authors:  Samuel Maiwald; Christopher Heim; Birte Hernandez Alvarez; Marcus D Hartmann
Journal:  ACS Med Chem Lett       Date:  2020-12-04       Impact factor: 4.345

5.  Replacing the phthalimide core in thalidomide with benzotriazole.

Authors:  Mikhail Krasavin; Andrey Bubyrev; Alexander Kazantsev; Christopher Heim; Samuel Maiwald; Daniil Zhukovsky; Dmitry Dar'in; Marcus D Hartmann; Alexander Bunev
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

6.  High-resolution structures of the bound effectors avadomide (CC-122) and iberdomide (CC-220) highlight advantages and limitations of the MsCI4 soaking system.

Authors:  Christopher Heim; Marcus D Hartmann
Journal:  Acta Crystallogr D Struct Biol       Date:  2022-02-18       Impact factor: 7.652

Review 7.  Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One.

Authors:  Alessandra Salerno; Francesca Seghetti; Jessica Caciolla; Elisa Uliassi; Eleonora Testi; Melissa Guardigni; Marinella Roberti; Andrea Milelli; Maria Laura Bolognesi
Journal:  J Med Chem       Date:  2022-07-11       Impact factor: 8.039

Review 8.  Current strategies for the design of PROTAC linkers: a critical review.

Authors:  Robert I Troup; Charlene Fallan; Matthias G J Baud
Journal:  Explor Target Antitumor Ther       Date:  2020-10-30

Review 9.  E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points.

Authors:  Aleša Bricelj; Christian Steinebach; Robert Kuchta; Michael Gütschow; Izidor Sosič
Journal:  Front Chem       Date:  2021-07-05       Impact factor: 5.221

10.  Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications.

Authors:  Laura Goracci; Jenny Desantis; Aurora Valeri; Beatrice Castellani; Michela Eleuteri; Gabriele Cruciani
Journal:  J Med Chem       Date:  2020-10-07       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.